Long-term results from the OLYMPIA open-label extension study show that nemolizumab (Nemluvio) provides durable efficacy and good tolerability for up to 3 years in patients with ...

The U.S. Food and Drug Administration has approved expanded use of Wellcovorin (leucovorin calcium) tablets for the treatment of cerebral folate deficiency in adult and pediatric patients with a ...

Drug's approval expanded, but only to patients with genetic cerebral folate transport defi ...

Cerebral folate deficiency is a rare neurological disorder characterized by a decrease in CSF folate levels, leading to developmental regression, seizures, movement disorders, and other neurological ...

The therapeutic landscape for cutaneous T-cell lymphoma (CTCL) is undergoing a significant shift with the emergence of denileukin diftitox (Lymphir), the first systemic treatment ...

This press release is intended for US audiences for transparency relative to global news for the Fabry community. This dosing regimen for ...

The FDA approved leucovorin for cerebral folate deficiency linked to FOLR1 mutations but said evidence is insufficient to support approval for autism.

Phase 2b study demonstrated greater reductions in inflammatory acne lesions with Ameluz® PDT versus vehicle• 3-hour incubation regimen ...

Cutaneous lupus erythematosus is a chronic autoimmune disease with few treatment options and no approved targeted therapies.

The U.S. Food and Drug Administration has approved expanded use of Wellcovorin (leucovorin calcium) tablets for the treatment of cerebral folate deficiency in adult and pediatric patients who ...

Report Highlights the Company's Collaboration with GARDP to Develop NUZOLVENCE (R) (zoliflodacin) for Oral Suspension for the Treatment of Uncomplicated Urogenital Gonorrhea in Adults and Pediatric ...

Dr. Aleksander Słusarczyk presented the clinical case of a 75-year-old woman who presented with a two-month history of hematuria. Her medical history was notable for diabetes, prior myocardial ...